Last reviewed · How we verify
NCT03252184
Effects of Photobiomodulation on Endothelial Function in Healthy Subjects
NA trial testing Low level laser therapy - 1 in Healthy Behavior in 16 participants. Status unknown.
30 December 2019
Quick facts
| Lead sponsor | Rodrigo Della Méa Plentz |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 16 |
| Start date | 1 September 2017 |
| Primary completion | 30 December 2019 |
| Estimated completion | 30 December 2020 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Low level laser therapy - 1
- Low level laser therapy - 2
- Low level laser therapy - 3
Conditions studied
- Healthy Behavior — all drugs for Healthy Behavior →
Sponsor
Rodrigo Della Méa Plentz
Who can join
Adults 18 to 40, any sex, with Healthy Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The endothelial cell layer is responsible for the control of vascular homeostasis, a process mediated by vasoconstricting and vasodilatory substances. The principal endothelium-dependent vascular dilator is nitric oxide (NO), and the reduction of its synthesis or bioavailability is the main cause for the development of endothelial dysfunction. The use of photobiomodulation may be beneficial in several clinical situations. At the endothelial level, the stimulatory effects on vascular endothelial growth factor, NO secretion, number of capillaries and proliferation of endothelial cells are outstanding. The objective of this study is to evaluate the effects of photobiomodulation on the arterial endothelial function of healthy individuals. The study design will be a randomized, crossover, clinical trial and the sample will be composed of subjects selected by the eligibility criteria, and randomly randomized according to the order of intervention of the groups. The hypothesis is that at the end of the protocol with photobiomodulation an increase in endothelial function and blood markers of endothelial function occurs, and no tissue temperature variation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of photobiomodulation therapy (PBMT) over endothelial function in healthy individuals: a preliminary crossover clinical trial.
Hauck M, Schardong J, Donini G, Normann TC, et al · · 2023 · cited 3× · PMID 37072603 · DOI 10.1007/s10103-023-03762-w
Verify or expand the search:
- PubMed search for NCT03252184
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03252184 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rodrigo Della Méa Plentz
- Last refreshed: 24 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03252184.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing